Sarah Cannon, the Cancer Institute of HCA Healthcare, embarked on a transformative initiative to manage the growing demand for CAR-T therapy. Faced with the increasing volume of potentially high-acuity cases and limited inpatient capacity, the goal was to safely transition a substantial portion of CAR-T therapy to an outpatient model. Through a partnership with Current...